These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9758286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
    Vincent J, Teng R, Dalvie DK, Friedman HL.
    Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
    Teng R, Girard D, Gootz TD, Foulds G, Liston TE.
    Antimicrob Agents Chemother; 1996 Mar; 40(3):561-6. PubMed ID: 8851571
    [Abstract] [Full Text] [Related]

  • 6. Oral bioavailability of trovafloxacin with and without food in healthy volunteers.
    Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076
    [Abstract] [Full Text] [Related]

  • 7. The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects.
    Vincent J, Hunt T, Teng R, Robarge L, Willavize SA, Friedman HL.
    Am J Surg; 1998 Dec; 176(6A Suppl):32S-38S. PubMed ID: 9935255
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
    Teng R, Harris SC, Nix DE, Schentag JJ, Foulds G, Liston TE.
    J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468
    [Abstract] [Full Text] [Related]

  • 9. Excretion and metabolism of trovafloxacin in humans.
    Dalvie DK, Khosla N, Vincent J.
    Drug Metab Dispos; 1997 Apr; 25(4):423-7. PubMed ID: 9107540
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
    Wise R, Mortiboy D, Child J, Andrews JM.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):47-9. PubMed ID: 8787877
    [Abstract] [Full Text] [Related]

  • 12. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.
    Dalvie DK, Khosla NB, Navetta KA, Brighty KE.
    Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers.
    Teng R, Liston TE, Harris SC.
    J Antimicrob Chemother; 1996 May; 37(5):955-63. PubMed ID: 8737145
    [Abstract] [Full Text] [Related]

  • 15. Penetration of trovafloxacin into gynecologic tissues.
    Martens MG, Maccato M, Van Hook C, Vincent J.
    Am J Surg; 1998 Dec; 176(6A Suppl):18S-22S. PubMed ID: 9935252
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.
    Gee T, Andrews JM, Ashby JP, Marshall G, Wise R.
    J Antimicrob Chemother; 2001 Apr; 47(4):431-4. PubMed ID: 11266415
    [Abstract] [Full Text] [Related]

  • 17. Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS.
    Lacy MK, Nicolau DP, Nightingale CH, Geffken A, Teng R, Vincent J, Quintiliani R.
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3005-7. PubMed ID: 10582898
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.
    Lister PD, Sanders CC.
    Antimicrob Agents Chemother; 1999 May; 43(5):1118-23. PubMed ID: 10223923
    [Abstract] [Full Text] [Related]

  • 20. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.
    Andrews JM, Honeybourne D, Brenwald NP, Bannerjee D, Iredale M, Cunningham B, Wise R.
    J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.